Download Nekaličte ľudí s artritídou! (Vrátane detí s juvenílnou artritídou

Nekaličte ľudí s artritídou!
(Vrátane detí s juvenílnou artritídou) Zdroje
1. Bennett
JC, Plum F, eds. Cecil textbook of medicine. Philadelphia, PA: WB Saunders. 1996: p
1459–1466
2. Tierney
LM, McPhee SJ, Papadakis MA, eds. Current medical diagnosis and treatment. Los Altos,
CA: Lange Medical. 1997: p 161
3. Smith
MD, Gibson RA, Brooks PM. Abnormal bowel permeability in ankylosing spondylitis and
rheumatoid arthritis. J Rheum 1985; 12: 299–305
4. Zaphiropoulos
GC. Rheumatoid arthritis and the gut. Br J Rheum 1986; 25: 138–140
5. Segal
AW, Isenberg DA, Hajirousou V et al. Preliminary evidence for gut involvement in the
pathogenesis of rheumatoid arthritis. Br J Rheum 1986; 25: 162–166
6. Ebringer
A, Khalapfour S, Wilson C. Rheumatoid arthritis and Proteus. A possible aetiological
association. Rheumatol Int 1989; 9: 223–228
7. Ebringer
A, Cox N, Abuljadayel AI et al. Klebsiella antibodies in ankylosing spondylitis and Proteus
antibodies in rheumatoid arthritis. Br J Rheum 1988; 2772–2785
8. Henriksson
AE, Blomquist L, Nord CE et al. Small intestinal bacterial overgrowth in patients with
rheumatoid arthritis. Annals Rheumatic Dis 1993; 52: 503–510
9. Philips
PE. Seminars in arthritis and rheumatism. Infectious agents in the pathogenesis of
rheumatoid arthritis. Semin Arthr Rheum 1986; 16: 1–100
10. Venables
P. Epstein–Barr virus infection and autoimmunity in rheumatoid arthritis. Ann Rheum Dis
1988; 47: 265–269
11. Clark
HW, Coker-Vann MR, Bailey JS, Brown TM. Detection of mycoplasmal antigens in immune
complexes from rheumatoid arthritis synovial fluids. Ann Allergy 1988; 60: 394–398
12. Wyburn-Mason
R. The naeglerial causation of rheumatoid disease and many human cancers. A
new concept in medicine. Med Hypotheses. 1979; 5: 1237–1249
13. Hall
GM, Spector TD. Depressed levels of dehydroepiandro-sterone sulphate in postmenopausal
women with rheumatoid arthritis but no relation with axial bone density. Annals Rheum Dis 1993; 52:
211–214
14. van
Vollenhoven RF et al. An open study of dehydroepiandrosterone in systemic lupus
erythematosus. Arthritis Rheum 1994; 37: 1305–1310
15. van
Vollenhoven R, Engleman EG, McGuire JL. Dehydroepiandrosterone in systemic lupus
erythematosus. Results of a double-blind, placebo-controlled, randomized clinical trial. Arthr Rheum
1995; 38: 1826–1831
16. Clegg
DO, Ward JR. Diagnostic criteria in rheumatoid arthritis. Scand J Rheum 1987; 65: 3–11
17. Nishiya
K, Matsueda H, Shirakami T et al. Serum and urinary ferritin levels in patients with
rheumatoid arthritis. Acta Med Okayama 1985; 39: 321–328
18. Jenkins
R, Rooney P, Jones D et al. Increased intestinal permeability in patients with rheumatoid
arthritis. A side effect of oral nonsteroidal anti-inflammatory drug therapy? Br J Rheum 1987; 26:103–
107
19. Fries
JF et al. Toward an epidemiology of gastropathy associated with nonsteroidal
antiinflammatory drug use. Gastroenterol 1989; 96: 647–655
20. Scott
DL, Symmons DP, Coulton BL et al. Long-term outcome of treating rheumatoid arthritis.
Results after 20 years. Lancet 1989; i: 1108–1111
21. Trowell
H, Burkitt D. Western diseases: their emergence and prevention. Cambridge, MA: Harvard
University Press. 1981
22. Darlington
LG, Ramsey NW. Clinical review. Review of dietary therapy for rheumatoid arthritis. Br J
Rheumatol 1993; 32: 507–514
23. Buchanan
HM, Preston SJ, Brooks PM et al. Is diet important in rheumatoid arthritis. Br J
Rheumatol 1991; 30: 125–134
24. McCrae
F, Veerapen K, Dieppe P. Diet and arthritis. Practitioner 1986; 230: 359–361
25. Darlington
LG, Ramsey NW, Mansfield JR. Placebo-controlled, blind study of dietary manipulation
therapy in rheumatoid arthritis. Lancet 1986; i: 236–238
26. Hicklin
JA, McEwen LM, Morgan JE. The effect of diet in rheumatoid arthritis. Clinical Allergy 1980;
10: 463–467
27. Panush RS. Delayed reactions to foods. Food allergy and rheumatic disease. Annals of Allergy
1986; 56: 500–503
28. Van
de Laar MAFJ, Ander Korst JK. Food intolerance in rheumatoid arthritis. I. A double-blind,
controlled trial of the clinical effects of elimination of milk allergens and azo dyes. Annals Rheum Dis
1992; 51: 298–302
29. Kjeldsen-Kragh
J et al. Controlled trial of fasting and one-year vegetarian diet in rheumatoid
arthritis. Lancet 1991; 338: 899–902
30. Skoldstam
L, Larsson L, Lindstrom FD. Effects of fasting and lactovegetarian diet on rheumatoid
arthritis. Scand J Rheumatol 1979; 8: 249–255
31. Kroker
GF, Stroud RM, Marshall R et al. Fasting and rheumatoid arthritis. A multicenter study.
Clinical Ecology 1984; 2: 137–144
32. Hafstrom
I, Ringertz B, Gyllenhammar H et al. Effects of fasting on disease activity, neutrophil
function, fatty acid composition, and leukotriene biosynthesis in patients with rheumatoid arthritis.
Arthr Rheum 1988; 31: 585–592
33. Kjeldsen-Kragh
J et al. Vegetarian diet for patients with rheumatoid arthritis - Status. Two years
after introduction of the diet. Clin Rheumatol 1994; 13: 475–482
34. Peltonen
R, Kjeldsen-Kvagh J et al. Changes in faecal flora in rheumatoid arthritis during fasting
and one-year vegetarian diet. Br J Rheumatol 1994; 33: 638–643
35. Peltonen
R, Nenonen M, Helve T et al. Faecal microbial flora and disease activity in rheumatoid
arthritis during a vegan diet. Br J Rheumatol 1997; 36: 64–68
36. De
Witte TJ, Geerdink PJ, Lamers CB et al. Hypochlorhydria and hypergastrinemia in rheumatoid
arthritis. Ann Rheumatic Dis 1979; 38: 14–17
37. Henriksson
K, Uvnas-Moberg K, Nord CE et al. Gastrin, gastric acid secretion, and gastric
microflora in patients with rheumatoid arthritis. Ann Rheumatic Dis 1986; 45: 475–483
38. Horger I. Enzyme therapy in multiple rheumatic diseases. Therapiewoche 1983; 33: 3948–3957
39. Ransberger
K. Enzyme treatment of immune complex diseases. Arthr Rheum 1986; 8: 16–19
40. Shapiro
JA, Koepsell TD, Voigt LF et al. Diet and rheumatoid arthritis in women. A possible
protective effect of fish consumption. Epidemiology 1996; 7: 256–263
41. Jantti
J, Nikkari T, Solakivi T et al. Evening primrose oil in rheumatoid arthritis. Changes in serum
lipids and fatty acids. Ann Rheum Dis 1989; 48: 124–127
42. Brzeski
M, Madhok R, Capell HA. Evening primrose oil in patients with rheumatoid arthritis and
side effects of non-steroidal anti-inflammatory drugs. Br J Rheumatol 1991; 30: 371–372
43. Belch
JJ, Ansell D, Madhok R et al. Effects of altering dietary essential fatty acids on requirements
for non-steroidal anti-inflammatory drugs in patients with rheumatoid arthritis. A double blind placebo
controlled study. Ann Rheum Dis 1988; 47: 96–104
44. Levanthal
LJ et al. Treatment of rheumatoid arthritis with gammalinoleic acid. Annals Int Med 1993;
119: 867–873
45. Kremer
J, Michaelek AV, Lininger L et al. Effects of manipulation of dietary fatty acids on clinical
manifestation of rheumatoid arthritis. Lancet 1985; i: 184–187
46. Kremer
J, Jubiz W, Michalek A et al. Fish-oil supplementation in active rheumatoid arthritis: a
double-blinded, controlled cross-over study. Ann Intern Med 1987; 106: 497–502
47. Sperling
R, Weinblatt M, Robin JL et al. Effects of dietary supplementation with marine fish oil on
leukocyte lipid mediator generation and function in rheumatoid arthritis. Arthritis Rheum 1987; 30:
988–997
48. Clelend
LG, French JK, Betts WH et al. Clinical and biochemical effects of dietary fish oil
supplements in rheumatoid arthritis. J Rheumatol 1988; 15: 1471–1475
49. Magaro
M, Altmonte L, Zoli A et al. Influence of diet with different lipid composition on neutrophil
composition on neutrophil chemiluminescence and disease activity in patients with rheumatoid
arthritis. Ann Rheum Dis 1988; 47: 793–796
50. van
der Tempel H, Tulleken JE, Limburg PC et al. Effects of fish oil supplementation in rheumatoid
arthritis. Ann Rheum Dis 1990; 49: 76–80
51. Kremer
JM, Lawrence DA, Jubiz W et al. Dietary fish oil and olive oil supplementation in patients
with rheumatoid arthritis. Arth Rheum 1990; 33: 810–820
52. Lau
CS, Gallacher C, Ross P et al. Maxepa on nonsteroidal anti-inflammatory drug usage in
patients with mild rheumatoid arthritis. Br J Rheumatol 1991; 30: 137
53. Nielsen
GL, Faarvang KL, Thomsen BS et al. The effects of dietary supplementation with n-3
polyunsaturated fatty acids in patients with rheumatoid arthritis. A randomized, double-blind trial. Eur
J Clin Invest 1992; 22: 687–691
54. Shukla
VKS, Perkins EG. The presence of oxidative polymeric materials in encapsulated fish oils.
Lipids 1991; 26: 23–26
55. Fritshe
KL, Johnston PV. Rapid autoxidation of fish oil in diets without added antioxidants. J Nutr
1988; 118: 425–426
56. Harats
D et al. Fish oil ingestion in smokers and nonsmokers enhances peroxidation of plasma
lipoproteins. Atherosclerosis 1991; 90: 127–139
57. Nettleton
JA. Omega-3 fatty acids. Comparison of plant and seafood sources in human nutrition. J
Am Diet Assoc 1991; 91: 331–337
58. Cunnane
SC et al. Alpha-linolenic acid in humans: direct functional role or dietary precursor.
Nutrition 1991; 7: 437–439
59. Mantzioris E, James MJ, Gibson RA et al. Dietary substitution with alpha-linolenic acid-rich
vegetable oil increases eicosapentaenoic acid concentrations in tissues. Am J Clin Nutr 1994; 59:
1304–1309
60. Kelley
DS. Alpha-linolenic acid and immune response. Nutrition 1992; 8: 215–217
61. Nordstrom
DC, Honkanen VE, Nasu Y et al. Alpha-linolenic acid in the treatment of rheumatoid
arthritis: a double-blind placebo-controlled and randomized study. Flaxseed vs. safflower oil.
Rheumatol Int 1995; 14: 231–234
V, Middleton E, Harborne JB. Plant flavonoids in biology and medicine – biochemical,
pharmacological, and structure-activity relationships. New York, NY: Alan R Liss. 1986; Cody V,
Middleton E, Harborne JB, Beretz A. Plant flavonoids in biology and medicine II – biochemical,
pharmacological, and structure activity relationships. New York, NY: Alan R Liss. 1988
62. Cody
63. Comstock
GW, Burke AE, Hoffman SC et al. Serum concentrations of alpha tocopherol, beta
carotene, and retinol preceding the diagnosis of rheumatoid arthritis and systemic lupus
erythematosus. Ann Rheum Dis 1997; 56: 323–325
64. Tarp
U, Overvad K, Hansen JC et al. Low selenium level in severe rheumatoid arthritis.
Scandinavian Journal of Rheumatology 1985; 14: 97–101
65. Tarp
U, Overvad K, Thorling EB et al. Selenium treatment in rheumatoid arthritis. Scandinavian
Journal of Rheumatology 1985; 14: 364–368
66. Munthe
E, Aseth J. Treatment of rheumatoid arthritis with selenium and vitamin E. Scandinavian
Journal of Rheumatology 1984; 53: 103
67. Pandley
SP, Bhattacharya SK, Sundar S. Zinc in rheumatoid arthritis. Indian Journal of Medical
Research 1985; 81: 618–620
68. Simkin
PA. Treatment of rheumatoid arthritis with oral zinc sulfate. Agents and Actions
(supplement) 1981; 8: 587–595
69. Mattingly
PC, Mowat AG. Zinc sulphate in rheumatoid arthritis. Ann Rheum Dis 1982; 41: 456–457
70. Pasquier
C, Mach PS, Raichvarg D et al. Manganese-containing superoxide-dismutase deficiency
in polymorphonuclear leukocytes of adults with rheumatoid arthritis. Inflammation 1984; 8: 27–32
71. Menander-Huber
KB. Orgotein in the treatment of rheumatoid arthritis. Europ J Rheum
Inflammation 1981; 4: 201–211
72. Zidenberg-Cherr
S, Keen CL, Lonnerdal B et al. Dietary superoxide dismutase does not affect
tissue levels. Am J Clin Nutr 1983; 37: 5–7
73. Rosa
GD, Keen CL, Leach RM et al. Regulation of superoxide dismutase activity by dietary
manganese. J Nutr 1980; 110: 795–804
74. Mullen
A, Wilson CWM. The metabolism of ascorbic acid in rheumatoid arthritis. Proc Nutr Sci
1976; 35: 8A–9A
75. Subramanian
N. Histamine degradation potential of ascorbic acid. Agents and Actions 1978; 8:
484–487
76. Levine
M. New concepts in the biology and biochemistry of ascorbic acid. New Engl J Med 1986;
314: 892–902
77. Barton-Wright
EC, Elliott WA. The pantothenic acid metabolism of rheumatoid arthritis. Lancet
1963; ii: 862–863
78. General
Practitioner Research Group. Practitioner 1980; 224: 208–211
79. Sorenson
JRJ, Hangarter W. Treatment of rheumatoid and degenerative disease with copper
complexes. A review with emphasis on copper salicylate. Inflammation 1977; 2: 217–238
80. Lewis
AJ. The role of copper in inflammatory disorders. Agents Actions 1984; 513–519
WR, Keats DM. An investigation of the therapeutic value of the “copper bracelet” – dermal
assimilation of copper in arthritic/rheumatoid conditions. Agents Actions 1976; 6: 454–458
81. Walker
82. Chung
MH, Kessner L, Chan PC. Degradation of articular cartilage by copper and hydrogen
peroxide. Agents Actions 1984; 15: 328–335
83. Sullivan
MX, Hess WC. Cystine content of finger nails in arthritis. J Bone Joint Surg 1935; 16: 185–
188
84. Senturia
BD. Results of treatment of chronic arthritis and rheumatoid conditions with colloidal
sulphur. J Bone Joint Surg 1934; 16: 119–125
85. Wheeldon.
The use of colloidal sulphur in the treatment of arthritis. J Bone Joint Surg 1935; 17:
693–726
86. Kaufman
W. The common form of joint dysfunction: its incidence and treatment. Brattleboro, VT:
E.L. Hildreth. 1949
87. Hoffer
A. Treatment of arthritis by nicotinic acid and nicotinamide. Canadian Medical Association
Journal 1959; 81; 235–239
88. Ammon
HPT, Wahl MA. Pharmacology of Curcuma longa. Planta Medica 1991; 57: 1–7
89. Sharma
OP. Antioxidant properties of curcumin and related compounds. Biochem Pharmacol
1976; 25: 1811–1825
90. Toda
S, Miyase T, Arich H et al. Natural antioxidants. Antioxidative compounds isolated from
rhizome of Curcuma longa L. Chem Pharmacol Bull 1985; 33: 1725–1728
91. Srimal
R, Dhawan B. Pharmacology of diferuloyl methane (curcumin), a non-steroidal antiinflammatory agent. J Pharm Pharmac 1973; 25: 447–452
92. Srivastava
R. Inhibition of neutrophil response by curcumin. Agents Actions 1989; 28: 298–303
93. Flynn
DL, Rafferty MF. Inhibition of 5-hydroxy-eicosatetraenoic acid (5-HETE) formation in intact
human neutrophils by naturally-occurring diarylheptanoids. Inhibitory activities of curcuminoids and
yakuchinones. Prost Leukotri Med 1986; 22: 357–360
94. Deodhar
SD, Sethi R, Srimal RC. Preliminary studies on antirheumatic activity of curcumin
(diferuloyl methane). Ind J Med Res 1980; 71: 632–634
95. Satoskar
RR, Shah SJ, Shenoy SG. Evaluation of anti-inflammatory property of curcumin
(diferuloyl methane) in patients with postoperative inflammation. Int J Clin Pharmacol Ther Toxicol
1986; 24: 651–654
96. Shankar
TNB, Shantha NV, Ramesh HP et al. Toxicity studies on turmeric (Curcuma longa): acute
toxicity studies in rats, guinea pigs & monkeys. Indian J Exp Biol 1980; 18: 73–75
97. Taussig
S, Batkin S. Bromelain: the enzyme complex of pineapple (Ananas comosus) and its
clinical application. An update. J Ethnopharmacol 1988; 22: 191–203
98. Cohen
A, Goldman J. Bromelain therapy in rheumatoid arthritis. Penn Med J 1964; 67: 27–30
99. Leung
A. Encyclopedia of common natural ingredients used in food, drugs, and cosmetics. New
York, NY: John Wiley. 1980
100. Kiuchi
F et al. Inhibition of prostaglandin: and leukotriene biosynthesis by gingerols and
diarylheptanoids. Chem Pharm Bull 1992; 40: 387–391
101. Srivastava
KC, Mustafa T. Ginger (Zingiber officinale) and rheumatic disorders. Med Hypothesis
1989; 29: 25–28
102. Srivastava
KC, Mustafa T. Ginger (Zingiber officinale) in rheumatism and musculoskeletal
disorders. Med Hypothesis 1992; 39: 342–348
103. Shimizu
K, Amagaya S, Ogihara Y. Combination of shosaikoto (Chinese traditional medicine) and
prednisolone on the anti-inflammatory action. J Pharmaco Dyn 1984; 7: 891–899
104. Yamamoto
M, Kumagai A, Yokoyama Y. Structure and actions of saikosaponins isolated from
Bupleurum falcatum L. Arzniem Forsch. 1975; 25: 1021–1040
105. Hiai
S, Yokoyama H, Nagasawa T et al. Stimulation of the pituitary-adrenocortical axis by
saikosaponin of Bupleuri radix. Chem Pharm Bull 1981; 29: 495–499
106. Hikino
H. Recent research on Oriental medicinal plants. Economic and Medicinal Plant Research
1985; 1: 53–85
107. Sukenik
S. Balneotherapy for rheumatoid arthritis at the Dead Sea. Isr Med J 1995; 31: 210–214